Silexion Therapeutics Corp
Organization details
- Legal name
- Silexion Therapeutics Corp
- Former names
- Biomotion Sciences
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Jurisdiction of incorporation
- Cayman Islands
- Headquarters city
- Ramat GAN
- Headquarters country
- Israel
- Fiscal year end
- December
- Ticker symbol
- SLXN
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0002022416
Board of directors
-
Amnon Peled · DirectorSince 2024
-
Avner Lushi · DirectorSince 2024
-
Dror Yosef Abramov · DirectorSince 2024
-
Ilan Hadar · Director · Chairman and CEOSince 2024
-
Ilan Levin · DirectorSince 2024
-
Ilan Shiloah · DirectorSince 2024
-
Ruth Alon · DirectorSince 2024
-
Shlomo Noy · DirectorSince 2024
Chief executives
Weak · grade F
Out of 100, from shareholder return, dividends, growth and acquisitions.
Partial: only 15% of the scoring weight is on file.
- Earnings growth 15%
- 0
-55% a year in earnings per share
15% of the scoring weight is on file. Figures cover December 2023 – December 2025.
Board connections
2 of this board's directors also sit on 2 other boards. 2 are in the same sector.
-
Alpha Tau Medical Ltd. Same sectorvia Ruth Alon
-
BrainsWay Ltd. Same sectorvia Avner Lushi
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $31,032
- 1 sale by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 4, 2026 | Shirvan Mitchell Officer (CSO and CDO) | Grant or award | +6,000 | — | — |
| Jun 4, 2026 | Horenshtein Hadar Mirit Officer (CFO and Secretary) | Grant or award | +7,500 | — | — |
| Jun 4, 2026 | Ilan Hadar Director, Officer (Chairman and CEO) | Grant or award | +10,000 | — | — |
| Mar 26, 2026 | Shirvan Mitchell Officer (CSO and CDO) | Open-market sale | −22,818 | $1.36 | $31,032 |
| Feb 20, 2026 | Shlomo Noy Director | Grant or award | +9,091 | — | — |
| Feb 20, 2026 | Ruth Alon Director | Grant or award | +9,091 | — | — |
| Feb 20, 2026 | Shirvan Mitchell Officer (CSO and CDO) | Grant or award | +49,726 | — | — |
| Feb 20, 2026 | Horenshtein Hadar Mirit Officer (CFO and Secretary) | Grant or award | +49,726 | — | — |
| Feb 20, 2026 | Ilan Hadar Director, Officer (Chairman and CEO) | Grant or award | +64,350 | — | — |
| Feb 20, 2026 | Dror Yosef Abramov Director | Grant or award | +9,091 | — | — |
| Feb 20, 2026 | Amnon Peled Director | Grant or award | +7,576 | — | — |
| Feb 20, 2026 | Avner Lushi Director | Grant or award | +9,091 | — | — |
| Sep 15, 2025 | Ilan Levin Director, 10% owner | Grant or award | +450,000 | $4.00 | $1,800,000 |
| Aug 7, 2025 | Ilan Levin Director, 10% owner | Other | −5,550 | — | — |
| Feb 9, 2025 | Dror Yosef Abramov Director | Grant or award | +794 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Silexion Therapeutics Corp
Who is the CEO of Silexion Therapeutics Corp?
Ilan Hadar has been Silexion Therapeutics Corp's Chairman and CEO since August 2024.
How many directors are on Silexion Therapeutics Corp's board?
Silexion Therapeutics Corp's board has 8 directors: Amnon Peled, Avner Lushi, Dror Yosef Abramov, Ilan Hadar, Ilan Levin, Ilan Shiloah, Ruth Alon and Shlomo Noy.
Are Silexion Therapeutics Corp insiders buying or selling shares?
Over the last 12 months, Silexion Therapeutics Corp insiders made no open-market purchases and sold $31,032 of shares in 1 sale on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="silexion-therapeutics-corp"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.